Società Omnicell, Inc.

OMCL

US68213N1090

Attrezzatura medica

Consensus Analisti

Attività

Vendite per attività

Vendite per regione

Dirigenti

Amministratori

Classe di azioni

Azionisti

Coordinate società

Società del gruppo

Settore

Vendite per attività

Vendite per regione

Rating per Omnicell, Inc.

Revisioni EPS

Utili trimestrali - Indice di sorpresa

Settore Software medico e servizi tecnologici

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 02/07/2024			Variaz. 5gg	Var. 1 gen.
26,16 ^USD	-1,84%		-1,73%	-30,48%

16/05	Transcript : Omnicell, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 03:40 PM
02/05	Le azioni di Omnicell salgono dopo che i risultati non-GAAP del Q1 e le entrate hanno battuto le stime	MT

Omnicell, Inc. è un fornitore di soluzioni di gestione dei farmaci e di strumenti di aderenza per sistemi sanitari e farmacie. L'azienda si concentra sulla trasformazione dell'assistenza farmaceutica attraverso un'innovazione incentrata sui risultati, volta a ottimizzare i risultati clinici e commerciali in tutti i contesti di cura, grazie a un portafoglio di robotica, dispositivi intelligenti, software intelligente e servizi. Le sue soluzioni di automazione del punto di cura sono progettate per migliorare i flussi di lavoro dei medici nelle aree di cura dei pazienti del sistema sanitario, come le unità infermieristiche, i reparti di degenza, le sale operatorie e i dipartimenti di emergenza. I sistemi di dispensazione automatica di farmaci e forniture della Serie XT dell'Azienda, utilizzati nelle unità infermieristiche e in altre aree cliniche dell'ospedale, sono progettati per supportare i flussi di lavoro specifici di ogni area dell'ospedale, con varie opzioni software e hardware. Per la sala operatoria, l'Azienda offre anche sistemi di dispensazione automatizzati specializzati.

Numero di dipendenti: 3 590

USD in Milioni	2022	Peso	2023	Peso	Delta
Connected Devices, Software Licenses, and Other 54,4 %	828	63,9 %	624	54,4 %	-24,68%
Technical Services 19,7 %	207	15,9 %	226	19,7 %	+9,26%
Advanced Services 18,5 %	186	14,4 %	213	18,5 %	+14,34%
Consumables 7,4 %	75	5,8 %	85	7,4 %	+12,84%

USD in Milioni	2022	Peso	2023	Peso	Delta
United States 88,2 %	1 168	90,1 %	1 011	88,2 %	-13,42%
Rest of World 11,8 %	128	9,9 %	136	11,8 %	+6,25%

Dirigenti	Titolo	Età	Da
Randall Lipps CEO	Chief Executive Officer	66	01/09/92
Nchacha Etta DFI	Director of Finance/CFO	-	01/06/23
Corey Manley ADM	Chief Administrative Officer	-	01/04/21
Giri Chodavarapu CTO	Chief Tech/Sci/R&D Officer	-	01/06/18
Minoo Mortazavi COO	Chief Operating Officer	-	01/09/20
Nish Parekh PRN	Corporate Officer/Principal	-	12/06/23
Kathleen Nemeth,		-	-
Vicki Gigliotti HRO	Human Resources Officer	-	01/10/04
Randy Lipps		-	-

Amministratori	Titolo	Età	Da
Mark Parrish BRD	Director/Board Member	68	01/01/13
Joanne Bauer BRD	Director/Board Member	68	01/01/14
Randall Lipps CEO	Chief Executive Officer	66	01/09/92
Edward Bousa BRD	Director/Board Member	65	07/07/21
Robin Seim BRD	Director/Board Member	64	18/03/19
Eileen Voynick BRD	Director/Board Member	69	05/01
Bruce Scott BRD	Director/Board Member	68	14/05/19
Mary Garrett BRD	Director/Board Member	65	24/05/22
Bobby Ghoshal BRD	Director/Board Member	55	06/07/23
Randy Lipps		-	-

	Voto	Quantità	Flottante	Autocontrollo	Flottante totale
Azione A	1	56 206 492	45 199 262 ( 80,42 %)	10 283 000 ( 18,30 %)	80,42 %

Nome	Azioni	%	Valorizzazione
BlackRock Advisors LLC 16,58 %	7 614 545	16,58 %	248 M $
Vanguard Fiduciary Trust Co. 12,31 %	5 651 732	12,31 %	184 M $
Cadian Capital Management LP 5,053 %	2 320 571	5,053 %	76 M $
STATE STREET CORPORATION 4,462 %	2 049 230	4,462 %	67 M $
Champlain Investment Partners LLC 3,818 %	1 753 205	3,818 %	57 M $
Pacer Advisors, Inc. 3,401 %	1 561 645	3,401 %	51 M $
BNY Mellon Investment Adviser, Inc. 2,807 %	1 289 263	2,807 %	42 M $
Eaton Vance Management 2,566 %	1 178 414	2,566 %	38 M $
DFA Australia Ltd. 2,428 %	1 114 816	2,428 %	36 M $
D.E. Shaw & Co., Inc. 2,354 %	1 080 909	2,354 %	35 M $

Omnicell, Inc.

4220 North Freeway

76137, Fort Worth

+877 415 9990

http://www.omnicell.com

Nome	Categoria e settore
Omnicell Srl Omnicell Srl Wholesale DistributorsDistribution Services Part of Omnicell, Inc., Omnicell Srl supplies robotic solutions and software automation solutions to the healthcare sector. The company is based in Trieste, Italy. The Italian company was founded by Marco Ottolini. Marco Ottolini has been the CEO since incorporation. Omnicell was acquired by Aesynt, Inc. on April 03, 2014.	Wholesale Distributors
Mach 4 Automatisierungs Technik GmbH Mach 4 Automatisierungs Technik GmbH Medical SpecialtiesHealth Technology MACH4 Automatisierungstechnik GmbH develops and produces automated medication repositories. Its products include primero, medimat, robomat, speed box, conveyor technology and unidose systems. The company was founded by Holger Wallat, Dirk Beils, Peter Jansen, and Markus Riedl in 1997 and is headquartered in Bochum, Germany.	Medical Specialties
Aesynt SRL
Omnicell SAS Omnicell SAS Wholesale DistributorsDistribution Services Part of Omnicell, Inc., Omnicell SAS is a French company that wholesales industrial equipment and supplies. The company is based in Vendenheim, France. The CEOs are Mohit Bhatia, Sara Dalmasso. The company was founded in 2006.	Wholesale Distributors
Aesynt Canada, Inc. Aesynt Canada, Inc. Medical SpecialtiesHealth Technology Part of Omnicell, Inc., Aesynt Canada, Inc. manufactures electromedical and electrotherapeutic apparatus. The company is based in Toronto, Canada.	Medical Specialties
Omnicell BV Omnicell BV Financial ConglomeratesFinance Omnicell BV provides investment services. The company is headquartered in Amsterdam, the Netherlands.	Financial Conglomerates
Omnicell GmbH (Hessen) Omnicell GmbH (Hessen) Industrial MachineryProducer Manufacturing Omnicell GmbH (Hessen) is a German company that provides automation solutions for drug management. Part of Omnicell, Inc., the company is based in Darmstadt, Germany. The company's technology supports hospitals and pharmacies with automated processes and data intelligence, reducing running costs, optimizing operational efficiency, and increasing patient safety. Omnicell has over 30 years of experience and expertise, working on four continents and helping millions of people worldwide. The company's solutions for medication adherence, medication storage, communication, and creation enable pharmacies to become the pharmacy of choice for their customers. Omnicell's solutions for central pharmacies and clinical care optimize clinical work processes and relieve nursing staff through efficient medication management within the clinic.	Industrial Machinery
Omnicell Ltd. Omnicell Ltd. Drugstore ChainsRetail Trade Part of Omnicell, Inc., Omnicell Ltd. is a British company that provides medication management solutions and adherence tools for health systems and pharmacies. The company is based in Manchester, UK. The company was founded in 1992 by Randall A. Lipps. Randall A. Lipps has been the CEO since 1992.	Drugstore Chains
Omnicell India Pvt Ltd.

Rating Trading

Rating Investimento

ESG Refinitiv

Altri rating

Vendita

Buy

Raccomandazione media

Accumulate

Numero di analisti

Ultimo prezzo di chiusura

26,16 USD

Prezzo obiettivo medio

33,14 USD

Differenza / Target Medio

+26,69%

Consenso

Revisioni delle Stime

Calendario della società

Servizi sanitari

Attrezzature e forniture per la sanità

Attrezzatura medica

Software medico e servizi tecnologici

	Variaz. 1 gen.	Capi.
OMNICELL, INC.	-30,48%	1,2 Mrd
VEEVA SYSTEMS INC.	-5,02%	29,56 Mrd
PRO MEDICUS LIMITED	+42,32%	9,46 Mrd
SECTRA AB	+33,70%	4,36 Mrd
EVOLENT HEALTH, INC.	-41,72%	2,21 Mrd
VERADIGM INC.	-7,91%	1,63 Mrd
LUNIT INC.	-42,86%	974 Mln
SIMULATIONS PLUS, INC.	+4,72%	936 Mln
B-SOFT CO.,LTD.	-46,87%	739 Mln
SURGICAL SCIENCE SWEDEN AB	-33,15%	581 Mln

Software medico e servizi tecnologici